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Abstract
Background: Delayed cord clamping at birth has shown to benefit neonates with increased placental transfusion
leading to higher haemoglobin concentrations, additional iron stores and less anaemia later in infancy, higher red
blood cell flow to vital organs and better cardiopulmonary adaptation. As iron deficiency in infants even without
anaemia has been associated with impaired development, delayed cord clamping seems to benefit full term
infants also in regions with a relatively low prevalence of iron deficiency anaemia. In Nepal, there is a high
anaemia prevalence among children between 6 and 17 months (72–78 %). The objective of the proposed
study is to evaluate the effects of delayed and early cord clamping on anaemia (and haemoglobin level) at
8 and 12 months, ferritin at 8 and 12 months, bilirubin at 2–3 days, admission to Neonatal Intensive Care
Unit (NICU) or special care nursery, and development at 12 and 18–24 months of age.
Methods/design: A randomized, controlled trial comparing delayed and early cord clamping will be
implemented at Paropakar Maternity and Women’s Hospital in Kathmandu, Nepal. Pregnant woman of
gestational age 34–41 weeks who deliver vaginally will be included in the study. The interventions will
consist of delayed clamping of the umbilical cord (≥180 s after delivery) or early clamping of the umbilical
cord (≤60 s). At 8 and 12 months of age, infant’s iron status and developmental milestones will be measured.
Discussion: This trial is important to perform because, although strong indications for the beneficial effect
of delayed cord clamping on anaemia at 8 to 12 months of age exist, it has not yet been evaluated by a
randomized trial in this setting. The proposed study will analyse both outcome as well as safety effects.
Additionally, the results may not only contribute to practice in Nepal, but also to the global community, in
particular to other low-income countries with a high prevalence of iron deficiency anaemia.
Trial registration: Clinical trial.gov NCT02222805. Registered August 19 2014.
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Background
At the time of birth, the infant is still attached to the
placenta via the umbilical cord. The infant is usually sep-
arated from the placenta by clamping the cord with two
clamps, and cutting between the clamps. This task takes
place during the third stage of labour, which is the
period of time from the birth of the infant to the delivery
of the placenta [1].
Active management of the third stage of labour has
been described in a recent World Health Organization
(WHO) report as the “cornerstone” of obstetric and
midwifery practice during the latter part of the 20th cen-
tury [2]. Active management has involved the clinician
intervening in the process of placental delivery through
three interrelated practices: the administration of an
uterotonic drug; early cord clamping and cutting; and
controlled traction of the umbilical cord.
Early cord clamping has generally been advised to be
completed within the first 30 s after birth, regardless of
whether cord pulsation has ceased [3]. Due to evidence
shown in the last decade, recent guidelines for active
management of the third stage of labour no longer rec-
ommend immediate cord clamping [4], but changes in
practice are still questioned [5] and policies in hospitals
are rare [6].
Delayed clamping allows time for a transfer of the
foetal blood in the placenta to the infant at the time of
birth. This placental transfusion can provide the infant
with an additional 40 % more blood volume [7]. The
amount of blood transferred to the infant depends on
when the cord is clamped and at what level the infant is
held prior to clamping [8]. Neonatal benefits associated
with this increased placental transfusion include higher
haemoglobin concentrations, additional iron stores and
less anaemia in early infancy and better cardiopulmonary
adaptation [1, 9, 10].
Delayed cord clamping has, however, been linked to
an increase in the incidence of jaundice which, in severe
cases, could have longer-term effects on the health and
development of the infant [1, 11].
Previous studies performed by the principal investiga-
tor in a high-income country have shown that delayed
cord clamping, compared with early clamping, resulted
in a reduced prevalence of neonatal anaemia [12]. Fur-
thermore, delayed cord clamping improved iron status
and reduced the prevalence of iron deficiency (ID) in in-
fants at four months of age without demonstrable ad-
verse effects [12–14]. As ID in infants even without
anaemia has been associated with impaired development
[15, 16], delayed cord clamping seems to benefit full
term infants even in regions with a relatively low preva-
lence of ID anaemia [12].
The improved iron stores at four to six months after
delayed cord clamping suggest that ID anaemia could be
reduced at eight to twelve months of age, but this could
not be shown in a later study by the principal investiga-
tors [17], possibly due to small sample size and low fre-
quency of ID anaemia. However, delayed cord clamping
was associated with improved fine motor function at
4 years of age [18]. Although ID anaemia is rare (3–9 %)
in high-income countries [19], the negative impact on
children’s health and development should not be under-
estimated. No randomized trial has evaluated the effect
of delayed versus early cord clamping on infants after
six months of age in a low-income country with high
prevalence of ID and anaemia. As anaemia is associ-
ated with extensive health effects, such as stunting,
fatigue and impaired neurodevelopment [20], reducing
anaemia in infants is an urgent need globally. In an
observational study from Peru, anaemia at eight
months of age was evaluated in infants born before
and after a hospital policy change from early to de-
layed cord clamping. The study resulted in a signifi-
cant reduction of anaemia by 16 % (from 75 to 59 %)
as well as a significantly higher level of haemoglobin
among infants [21].
In Nepal, there is a high prevalence of anaemia among
children aged 6–17 months (72–78 %) [22]. Approxi-
mately 50 % of all anaemia among pre-schoolers can be
contributed to ID [23]. By performing the planned study
in a country with high anaemia prevalence, we aim to
evaluate any significant effects on haemoglobin levels
and neurodevelopment outcomes after different timing
of umbilical cord clamping in this high-risk population.
Study objective
To evaluate the effects of delayed and early cord clamp-
ing on:
1. Anaemia (and haemoglobin level) at 8 and
12 months
2. Ferritin at 8 and 12 months
3. Bilirubin at 2–3 days
4. Admission to the NICU or special care nursery
5. Development at 12 and 18–24 months of age.
Primary outcome
The primary outcome will be pre-specified infant haemo-
globin at 8 month of age.
Anaemia will be defined as altitude corrected haemo-
globin less than 110 g/L.
Secondary outcomes
The secondary outcomes will be
 Haemoglobin at 12 months
 Ferritin at 8 and 12 months; definition iron
deficiency as ferritin less than 12 μg/L
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 Iron deficiency anaemia at 8 and 12 months, defined
as both ferritin and haemoglobin below the
respective cut offs
 Other outcomes will be hyperbilirubinemia at
discharge, breast-feeding and morbidity during the
first six months of life and psychomotor develop-
ment at 12 months.
Methods
Study design and participants
This will be a randomized control trial in a hospital of
Nepal with two parallel groups (1:1 ratio), delayed
cord clamping (≥180 s) and early cord clamping
(≤60 s). The study will be conducted in Paropakar
Maternity and Women’s Hospital, a public funded
tertiary centre for obstetric and gynaecological ser-
vices in Kathmandu, Nepal.
In the hospital there are two separated delivery de-
partments, high risk-labour room (LR) and low risk-
Maternal and Neonatal Service Center (MNSC). At
admission, according to the hospital protocol, the
pregnant women are screened by an obstetrician who
made the decision to which department the women
will be transferred.
The hospital criteria for admission to MNSC are-
uncomplicated pregnancies, no complication at the time
of admission and healthy mothers (no clinical history of
hypertension, infection, diabetes, chronic medical condi-
tion), expected vaginal delivery, gestational age between
34 and 41 weeks and singleton pregnancy.
Women will be eligible to participate in the study if
they are assigned to MNSC. The exclusion criteria will be
serious congenital malformation, syndromes, or the other
congenital disease that could affect the outcome mea-
sures. Written consent will be obtained from the women
who were eligible and willing to participate (Fig. 1).
Randomization
The principal investigator will prepare a random list
using random digit generator in Microsoft excel and will
not have clinical involvement in the trial. Following this,
he will prepare sequentially numbered, opaque envelopes
and put in the colour cards with details of the allocated
group and sealed the envelopes.
These will be kept at the research office and will be
brought in the delivery unit before randomization.
Randomization will take place a few minutes before
delivery when the nurse-midwife considered vaginal de-
livery is imminent. To allocate the women into treat-
ment group, the surveillance officer (SO) will open the
next consecutively numbered envelope and inform the
nurse-midwife of the assigned treatment. The used
colour card and envelope will be discarded.
Surveillance protocol
Before the study period, early clamping was predomin-
ately practiced at the hospital. During the study period,
surveillance officers (SO) are stationed 24 h a day at
three stations, the reception, the delivery ward, and the
postnatal wards. SO are all trained nurse-midwives.
As the pregnant woman arrives at the hospital, she will
receive written information about the study in the recep-
tion. A SO will then approach the woman and ask for
her consent to participate in the study.
If the woman agrees, she will sign the consent form
and the SO stationed at the reception will register the
information needed according to protocol. The woman’s
labour will be managed by following the hospital’s ordin-
ary routine until she is transferred to the delivery ward,
where the randomisation takes place. The SO stationed
at the delivery ward will pair the woman with a sealed,
numbered, opaque envelope containing the treatment al-
location and show this to the nurse-midwife conducting
the delivery.
Intervention
When delivery is imminent (expected within 10 min),
the nurse-midwife will open the sealed, numbered,
opaque envelope to reveal the treatment allocation. The
interventions consist of delayed clamping of the umbil-
ical cord (≥180 s after delivery) or early clamping of the
umbilical cord (≤60 s). The SO will measure the time
from complete delivery of the baby until the first clamp is
placed on the umbilical cord with a stopwatch. All other
aspects of obstetric care will be managed according to
standard practice at the hospital. Should the infant need
resuscitation, the umbilical cord will be clamped and cut
and the infant will be carried to the resuscitation table for
further handling. In both groups, oxytocin will be given to
the mother after the umbilical cord is clamped. All staff in
the delivery unit will be trained in the study procedures
before the trial is started.
Follow-up
After delivery, the babies will be cared for according to
standard clinical routines, and early breast-feeding will
be encouraged. As part of the study, the nurse-midwife
will assess the infant at 1 and 6 h, to see whether the
baby has been breastfed Infants will stay at the postnatal
ward with their mothers for two or three days after de-
livery, except for those well babies whose mothers prefer
to leave the hospital earlier and infants who require ad-
mission to the neonatal unit. The SO stationed at the
postnatal ward will perform transcutaneous bilirubin
measurements when child and mother are discharged
from the hospital, as well as 24 and 48 h after delivery if
possible. The following information will be collected from
maternal healthcare records: background information of
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the mother’s age and parity, babies’ weight, gestational age
and Apgar score.
Monthly, up to 12 months of age, a SO will call the
family and ask questions regarding infections, breast-
feeding and immunizations of the infant.
At 8 and 12 months of age, infants will be scheduled for
a follow-up visit including blood sampling (haemoglobin
and ferritin). Venous blood sampling will be performed.
Mother’s will be interviewed about the infant’s feeding
practice.
At 12 months of age, the Ages & Stages Question-
naire will be used to record infants’ neurodevelop-
ment. Parents will be assisted in answering the Ages &
Stages Questionnaire.
Admission to the hospital 
Screening for eligibility criteria for admission in low risk delivery unit  (Maternal and Neonatal 
Service Center) 
Not eligible for randomization 
Declined to participate 
Randomization (N=540)
Allocated to early clamping (   60 s)
Receives allocated intervention 
Does not receive allocated intervention
Congenital anomaly
Instrumental delivery
No record of timing available
Stillbirth
Allocated to delayed clamping (   180 s)
Receives allocated intervention 
Does not receive allocated intervention
Cord around the neck
Non-breathing baby
Congenital anomaly
No record of timing available
Lost to follow up at 8 month 
Death
Lost to follow up at 8 month
Death
Analyzed at 8 month
Participate
Receives allocated intervention
Declined to participate 























Admitted to low risk delivery unit
Analyzed at 12 month
Participate
Receives allocated intervention 
Declined to participate 
Analyzed at 12 month
Participated
Receives allocated intervention 
Declined to participate 
Fig. 1 Trial profile (CONSORT flowchart)
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If funding is obtained, the Bayley Scales of Infant and
Toddler Development, third edition will be used to
examine children at 18–24 months of age.
Blinding
The study design precluded either the mother giving
birth or the nurse-midwife performing the intervention
being blinded. Physicians performing neonatal examina-
tions, staff members responsible for collection of blood
samples and background data, and laboratory staff per-
forming analyses of blood samples will be blinded to
each infant’s allocation group.
Sample size
The sample size for the primary outcome at eight
months was estimated in order to find a difference of
15 % (70 versus 55 %) in the prevalence of anaemia be-
tween the two randomization groups with a power of
80 % and a type I error rate of .05. Using Fisher’s exact-
test to analyse outcome data, a group size of 176 would
be needed. Taking into account an attrition rate of 35 %
we calculated that 270 newborns should be included in
each group, i.e. a total of 540.
Timeline
The study will begin on October 2, 2014 with the ex-
pected enrolment of the 540 participants within 45 to
60 days of the project start date.
Data management
The SO will fill up and assess data records. The two re-
search managers will verify all record forms with the pri-
mary source of data. A data entry officer will re-check
them for discrepancies before entering the data in com-
puters. The quality control team from Uppsala Univer-
sity will provide oversight to ensure quality of data
collection and to avoid data loss. A protocol for data
tracking will be followed. All cases will be analysed on
an intention to treat basis.
The Census and Survey Processing System (CSPro),
a public domain software package developed and sup-
ported by the U.S. Census Bureau and ICF Macro, will
be used for quality data management. CSPro is inter-
faced with SPSS (originally, Statistical Package for the
Social Sciences, 20), which will be used for statistical
analysis, data management (case selection, file reshap-
ing, creating derived data), and data documentation.
Hard copies of records will be stored in a filing system
in a secure room. Data will be checked for accuracy,
consistency, and completeness in both CSPro and
SPSS. An analysis plan will be developed in accord-
ance with the reporting guidelines. A profile and com-
parison of key variables between groups at baseline
will be presented.
Ethical considerations
All research involving newborn infants and small chil-
dren needs careful ethical consideration, mainly since
the subjects themselves cannot agree to whether they
want to participate in the study or not. In particular, re-
search that is not immediately beneficial for the patients
needs special ethical consideration. The included infants
are healthy full-term infants undergoing umbilical cord
clamping, which is a standard procedure after birth. The
possible benefit of the intervention (delayed cord clamp-
ing) for increasing iron stores and preventing infant
anaemia is estimated to be higher than the risk of prob-
able adverse effects, such as hyperbilirubinemia. Ethical
approval has been sought and obtained from Nepal
Health Research Council (Reg no. 76/2014) on 5 June
2014. The trial has been registered at clinicaltrial.gov
with the registration number NCT 02222805 on August
19, 2014. Written informed parental consent will be ob-
tained before the intervention is given, and parents can
withdraw from the study at any time without any need
for explanation.
Discussion
Reducing ID among infants is important, as it is associ-
ated with impaired neurodevelopment [16]. With a high
global prevalence of infant anaemia, delayed cord clamp-
ing has the potential to reduce infant anaemia and
thereby improve infants’ and children’s health and devel-
opment. In crude numbers, a reduction by 10 % would
mean an annual reduction of 60,000 infants with an-
aemia in Nepal. This trial is important to perform be-
cause, although strong indications for the beneficial
effect of delayed cord clamping on anaemia at 8 to
12 months of age exist, it has not been evaluated by a
randomized trial in a low-income setting with a high
prevalence of ID and anaemia. By completion of the pro-
posed study, both outcome as well as safety effects will
be analysed. Additionally, the results may not only con-
tribute to the practice in Nepal, but also to the global
community, in particular to other low-income countries
with a high prevalence of ID anaemia.
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